Allergy & Immunology Doctors in Orange, CA Accepting Medicare

8 Allergy & Immunology doctors found. Showing 1 - 8

Dr. Sarah Samimi Field, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 725 W La Veta Ave, Ste 100, Orange, CA 92868 Phone: 714-633-6363

Dr. Joseph Nguyen, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5691

Donald Levy, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 705 W La Veta Ave Ste 101, Orange, CA 92868 Phone: 714-639-7847    Fax: 714-639-1978

Dr. Chao-i Lin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1140 W La Veta Ave Ste 850, Orange, CA 92868 Phone: 714-771-7994    Fax: 714-744-4167

Dr. Alan E. Gorenberg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8506 E Chapman Ave, Orange, CA 92869 Phone: 714-633-4666    Fax: 714-633-4640

Dr. Stanley Paul Galant, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1201 W La Veta Ave, Ste 501, Orange, CA 92868 Phone: 714-771-7994    Fax: 714-744-4167

Dr. William G Harris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1140 W La Veta Ave Ste 850, Orange, CA 92868 Phone: 714-771-7994    Fax: 714-744-4167

Dr. Wan-yin Chan, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 W La Veta Ave Ste 100, Orange, CA 92868 Phone: 714-633-6363

News Archive

State highlights: Mass. facing cost decisions; Ore. boosting coordinated care; Lawyers tackling Calif. disparities

After passing universal coverage, Massachusetts is now in the throes of a debate about how to bring down its skyrocketing health care costs. And the state's new proposal to regulate how much providers charge for health care could mark a very important and controversial chapter in that fight.

Concerns raised about popular blood pressure, diabetes drugs

The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic cancer, a discovery that turned the doctor into a crusader.

New noninvasive technique to detect colorectal and gastric cancers found

A preliminary evaluation of methylation of two gene promoters in fecal DNA showed promise as a noninvasive method to detect colorectal and gastric cancers, according to a new study published online August 21 in the Journal of the National Cancer Institute.

Report highlights deprivation gap caused by late diagnosis of cancer, differences in treatment choices

There could be as many as 14,000 fewer cases of cancer each year in England if everyone was as healthy as the richest 20 per cent in the country. And the difference between the classes is more marked among men than women. Among men there were 21 per cent more cases of cancer in the most deprived areas compared to the least deprived, whereas the gap among women was 11 per cent.

Third-quarter fiscal 2009 results announced by Magellan Health Services

Magellan Health Services, Inc. today reported net income of $31.0 million, or $.88 per diluted common share, and segment profit of $64.5 million for the third quarter of 2009. The Company also increased guidance for the full year to the upper half of its previously disclosed range.

Read more Medical News

› Verified 5 days ago